jueves, 29 de enero de 2009

Inside the Preemie Brain

December 1, 2005 — Designed by a team of doctors, nurses, and engineers, a specially designed incubator allows premature babies to receive MRI scans to assess their health. The scans can measure many indicators, such as the levels of various metabolic substances in the body, to reveal whether or not a baby may have developmental problems, enabling parents to take therapeutic steps sooner for their children.

SAN FRANCISCO--Babies born prematurely face a host of health concerns, including future developmental problems. Now, a new kind of incubator helps doctors get a better look inside premature babies' brains.

MRI images can help doctors determine which babies will have these problems, but getting those images can be dangerous. Now, new technology solves the problem and keeps the babies safe.

When it comes to preemies -- everything is little -- including their brains. Imaging a premature baby's brain can be tricky. For years, doctors only used ultrasounds because transporting a baby to an MRI unit is dangerous.

Jim Barkovich, a pediatric neuro-radiologist at UCSF Children's Hospital in San Francisco, says, "You really worry about their blood pressure because their blood pressure can drop just from moving them too much."

Dr. Barkovich is using this specially designed incubator conceived by a team of doctors, nurses and engineers. It rolls right up to the MRI machine and allows doctors to get a clearer picture. "You can look at it to see the metabolites of the brain and whether the metabolites are normal or abnormal," he says.

The metabolites are just one of many indicators that reveal whether a baby may have developmental problems. The incubator provides constant heat and has built-in oxygen tanks. A strap keeps the baby's head in place. Special cables allow nurses to monitor heart rate and blood pressure, and a camera lets them see the baby.

After 106 days in the hospital, Kathy Ramsey and Andrew Ramsey now have baby Martha home. Martha was born prematurely and as all premature babies do, needed hospital care for many weeks following her birth. "It was a day we were looking forward to for a long time," Kathy says.

As part of the study, Martha used the MRI incubator two times and didn't seem to mind it. Andrew says, "She slept through both of them." Luckily, Martha's scans came back normal. Now, everyone can rest a little easier.

The special unit is now used at a handful of hospitals across the country.

BACKGROUND: Scientists at the University of California, San Francisco, are making MRI safer for premature babies by using a transportable incubator that is compatible with MRI machines. This will enable doctors to peer into the brain of such infants to determine which areas are most affected by the stress of premature birth.

THE PROBLEM: There is no inherent health risk with using MRI on a premature baby, but getting the infant in and out of the scanner is time-intensive process that involves great risk. Too much handling, or even a loud noise, can cause life-threatening complications in a premature baby, most commonly irregular heart rate and breathing patterns.

THE SOLUTION: The UCSF scientists collaborated with General Electric to design the MRI-compatible incubator -- currently the only one of its kind. It has already vastly improved the screening of premature babies. The incubator is made entirely of plastic, aluminum or brass, since anything magnetic would be attracted to the powerful magnets used in the MRI machine. It is essentially a capsule of double-paned Plexiglass that holds in heat. The infant can breath fresh warmed air piped in from the outside. Often a sedative is used so that the baby falls asleep, since an MRI scan is slow and can take as long as an hour.

ABOUT PREEMIE BRAIN DAMAGE: Roughly half of early premature births show subtle abnormalities in the brain that may be linked to later developmental problems. Yet it is often difficult to spot this damage early with traditional ultrasound; problems often don't become apparent until around 10 months of age. An early MRI scan can help doctors detect brain damage early enough so that therapy can improve the infant's chances of developing normally. The possible causes of brain damage in premature infants are not fully established, but include infection stemming from the wall of the uterus or placenta; the inability of an immature cardiovascular system to pump enough oxygen-rich blood to the brain; and an inflammatory response at birth.

Baby Thinking

Radiologists Use Light To Scan The Inner Workings Of The Brain

December 1, 2007 — Radiologists have developed a new device to understand brain activity. It is a collection of fiber optic cables attached to a flexible cap placed atop the head. The cables send near-infrared light through the skull and into the brain, where it is diffused or scattered before it is collected by receiver cables. The device is able to interpret the light to measure blood circulation and the amount of oxygen in that blood, which helps explain brain activity.

When doctors want to find out what's going on inside a baby's brain it usually requires, noisy or dangerous equipment and babies sitting completely still.

But, new technology is now giving researchers a fascinating look inside an infant’s brain in a much easier way.

Radiologists are using a new technique to see what parts of a baby’s brain are working during any given task. Their method is baby-friendly with no exposure to radiation or loud machines.

“It has a more wearable cap so it can be placed in infants heads while they sit in their parents lap,” Joseph Culver, Ph.D., Washington University Medical School said. Culver and his colleagues improved a brain imaging technique called high-density diffuse optical tomography.

It measures how much blood and oxygen are in the brain.

“It’s similar to taking a flashlight and putting it on one side of your hand and looking at the light come through your hand so the light has traveled through your hand and the light that you detect on the other side tells you something about what’s inside your hand,” Dr. Culver said. Fiber optic cables on the cap shine light on the baby’s brain. The light scatters revealing blood flow related to brain activity in a 3D tomographic image. You can see it in action, when a patient watches a flickering light; a similar rotating pattern shows up in the brain’s blood flow.

“There’s an increase in blood flow to that area and that allows us to map that neuron activity,” Dr. Culver said.

Future uses for the cap include researching brain development in the tiniest of babies … or monitoring a baby’s brain during surgery.

BACKGROUND: Researchers have developed a new brain imaging technique for infants called high-density diffuse optical tomography which helps them to study the developing infant brain. This should help treat infant brain injuries by being able to monitor them in their incubators, and help scientists learn important basics about developing brains. The new scanner is quieter, and portable because it is much smaller – about the size of a small refrigerator – than typical MRI or CT scan machines. The developers are working to make the unit even smaller, about the size of a microwave.

THE PROBLEM: Scientists have been able to study brain scans of infants while they are asleep or sedated using functional MRI (magnetic resonance imaging). Ideally researchers would like to scan their brains while sitting on a parent’s lap or interacting with their environment. fMRI requires the patient to be inserted into a tightly confined passage through a large, noisy magnet; most infants find it upsetting and difficult to sit still in that environment. In the same way CT scans involve large, loud equipment, and also expose patients to levels of x-rays considered unsafe for infants.

HOW IT WORKS: The high-density diffuse optical tomography (DOT) uses harmless light from the near-infrared light spectrum. Unlike X-rays or ultrasound, near-infrared light passes through bone easily, so scientists can use the diffusing light to determine blood flow and oxygenation in the blood vessels of the brain. When these characteristics increase, it indicates that the area of the brain they are scanning is contributing to a mental task. To scan a patient, scientists attach a flexible cap that covers the exterior of the head above the region of interest. Inside the cap are fiber optic cables. Some of those cables shine light on the head and by determining the way the light is scattered, researchers can learn more about brain activity. Light passes out of one fiber optic cable, goes through the tissue, and is received by another cable. Based on its interpretation of the diffusion data, the machine creates a 3D image based on whether the red blood cells have lots of oxygen or less oxygen to determine brain activity.

WHAT IS fMRI: Magnetic resonance imaging uses radio waves and a strong magnetic field to take clear and detailed pictures of internal organs and tissues. fMRI uses this technology to identify regions of the brain where blood vessels are expanding, chemical changes are taking place, or extra oxygen is being delivered. These are indications that a particular part of the brain is processing information and giving commands to the body. As a patient performs a particular task, the metabolism will increase in the brain area responsible for that task, changing the signal in the MRI image. So by performing specific tasks that correspond to different functions, scientists can locate the part of the brain that governs that function.


First Gene Discovered For Most Common Form Of Epilepsy

ScienceDaily (Jan. 29, 2009) — An international team of researchers, led by investigators at Columbia University Medical Center, has uncovered the first gene linked to the most common type of epilepsy, called Rolandic epilepsy. One out of every five children with epilepsy is diagnosed with this form, which is associated with seizures starting in one part of the brain.

The finding is the first step in unlocking the causes of common childhood epilepsies and developing more effective treatments. Children with Rolandic and other types of epilepsies are usually treated with drugs that prevent seizures by suppressing electrical activity in the entire brain.

"Epilepsy medications are effective for many children but there is concern that some of the cognitive and behavioral problems that children with epilepsy often suffer might be attributable in part to these drugs," says the study's senior author, pediatric neurologist Deb Pal, M.D., Ph.D., Columbia University research scientist in the Department of Psychiatry at the College of Physicians & Surgeons and at the Mailman School of Public Health and in the Division of Epidemiology at the New York State Psychiatric Institute. "Most epilepsies have a genetic influence, much of which has yet to be discovered. If we knew the actual genetic causes, then we could try to stop or reverse the processes that lead to seizures and other neurological impairments. This finding will hopefully help lead us to the right intervention."

In the study, the researchers searched the entire genome of 38 families and found a region on chromosome 11 that was linked with Rolandic epilepsy. Then, by comparing this region in people with Rolandic epilepsy to unaffected controls (255 people in total), the researchers pinpointed the gene, called ELP4.

The finding was replicated in a completely different set of patients and controls collected by the team's Canadian members, with the same result. Though Dr. Pal says an outside group still needs to replicate the findings, the two independent experiments provide strong evidence that ELP4 is truly linked to Rolandic epilepsy.

ELP4 has never before been linked to a human disease but is related to a group of genes (transcriptional regulators) that recently have been associated with other common forms of epilepsy. All these genes appear to influence the organization of brain circuits during development.

The discovery of genes like ELP4 are slowly altering the prevailing view of the cause of common epilepsies. Instead of stemming from changes in the brain's ion channels, as previously thought, the disorders likely stem from the way the brain's neurons connect to each other during development, researchers now believe.

With that perspective, it is not surprising that children with epilepsy often have other learning and behavior problems. "We shouldn't think of epilepsy as just about the seizures, but also about all the other brain impairments we see, like a delay in speaking, reading difficulties, and attention problems," Dr. Pal says. "Seizures are one, but not the only, consequence of these children's slightly altered brain development."

The findings also offer possible insights into the causes of attention deficit hyperactivity disorder (ADHD), speech dyspraxia (a speech disorder in which a person has a delay in speech development due to motor coordination difficulties), and developmental coordination disorder (DCD). Children with these developmental disorders often have the same spiky brainwave pattern that is present in children with Rolandic epilepsy. Understanding how the ELP4 gene is related to the brainwave pattern may help researchers uncover the causes of these disorders.

Rolandic epilepsy, named for the region of the brain affected by the seizures, begins almost exclusively in children between the ages of 3 and 12. Seizures typically start in the morning just after the child wakes up and cause a loss of muscle tone in the face and a loss of speech. Seizures stop on their own after several minutes. Most children grow out of the disorder by adolescence.

Additional authors of this study include Lisa Strug, Ph.D., formerly an assistant professor with Columbia University Mailman School of Public Health’s Department of Biostatistics, Division of Statistical Genetics.

Results of the study were published in an advance online issue of the European Journal of Human Genetics on January 28, 2009.Publicar entrada

The study was supported by members of the Partnership for Pediatric Epilepsy Research (American Epilepsy Society, Epilepsy Foundation, Anna and Jim Fantaci, Fight Against Childhood Epilepsy and Seizures, Neurotherapy Ventures Charitable Research Fund, Parents Against Childhood Epilepsy); Epilepsy Foundation, through the generous support of the Charles L. Shor Foundation for Epilepsy Research, Inc.; and the NIH.

Higher Blood Glucose Linked To Lower Cognitive Function

A sub-study of a trial looking at the effect of diabetes on heart disease risk found that higher levels of hemoglobin A1C levels (a measure of a person's average blood glucose over a 2 to 3 month period) were linked to lower cognitive function. 

The research was published online in the peer-reviewed journal of the American Diabetes Association, Diabetes Care on 26 January, and is part of the ongoing Memory in Diabetes (MIND) study, a sub-study of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 

Previous studies have suggested that people with diabetes have a 1.5 times higher chance of experiencing cognitive declien and dementia than people that don't have diabetes: the results from this MIND research suggests diabetes may be linked with mild cognitive impairment.

Lead investigator Dr Tali Cukierman-Yaffe, who is from the Gertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute at Sheba Medical Center and Sackler School of Medicine at Tel-Aviv University in Israel, said:

"Even a mild impairment in cognitive function is of concern for people with type 2 diabetes."

The overall ACCORD-MIND study is looking at whether the rate of structural brain change and cognitive decline in 2,800 people with diabetes differes according to whether they get standard care or intensive care. 

We should note that the results that are published in this paper are from a cross-sectional view of the data: that is the links they found don't tell you if the higher blood glucose is responsible for the lower cognitive function or whether somehow, cognitive impairment decreases the body's ability to control blood sugar, or it may even be a third, yet undiscovered factor that links the two.

Such a causal link can only be established by following study patients over a period of time and testing them at intervals during the trial. That is the plan with the ongoing ACCORD-MIND study, where one of the ideas being tested is whether lowering A1C improves cognitive function.

Meanwhile, in these interim results, the researchers found that poorer performance in three cognitive tasks that tested memory, speed and multi-tasking skills, and a lower score on an overall test of cognitive function, were all linked to higher levels of A1C hemoglobin.

The tests they used were: the Digit Symbol Substitution Test (DSST), Mini Mental Status Examination (MMSE), Rey Auditory Verbal Learning Test, and the Stroop Test.

The results showed:
  • A statistically significant link between A1C and all 4 tests, even after adjusting for age.

  • Specifically, the results were: 1 per cent higher A1C linked to significant 1.75 decrease in DSST score; 0.20 lower MMSE score; 0.11 lower memory score; and 0.75 s or more (ie worse) score on the Stroop Test.

  • The link between the DSST score and A1C persisted through all the statistical models they ran.

  • The researchers also measured fasting plasma glucose, but this did not show any links with test results.
The researchers concluded that:

"Higher A1C levels are associated with lower cognitive function in individuals with diabetes."

"The effect of glucose lowering on cognitive function will be determined by the ongoing ACCORD-MIND trial," they added.

"Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial."
Tali Cukierman-Yaffe, Hertzel C. Gerstein, Jeff D. Williamson, Ronald M. Lazar, Laura Lovato, Michael E. Miller, Laura H. Coker, Anne Murray, Mark D. Sullivan, Santica M. Marcovina, Lenore J. Launer for the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators.
Diabetes Care 32: 221-226, 2009
DOI: 10.2337/dc08-1153